AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
NODULAR HISTOGENETIC TYPE - THE MOST SIGNIFICANT FACTOR FOR THICK MELANOMA - IMPLICATIONS FOR PREVENTION
Authors: BERGENMAR M RINGBORG U BRAHME EM BRANDBERG Y
Citation: M. Bergenmar et al., NODULAR HISTOGENETIC TYPE - THE MOST SIGNIFICANT FACTOR FOR THICK MELANOMA - IMPLICATIONS FOR PREVENTION, Melanoma research, 8(5), 1998, pp. 403-411
DACARBAZINE-VINDESINE VERSUS DACARBAZINE-VINDESINE-CISPLATIN IN DISSEMINATED MALIGNANT-MELANOMA - A RANDOMIZED PHASE-III TRIAL
Authors: JUNGNELIUS U RINGBORG U AAMDAL S MATTSSON J STIERNER U INGVAR C MALMSTROM P ANDERSSON R KARLSSON M WILLMAN K WIST E BJELKENGREN G WESTBERG R
Citation: U. Jungnelius et al., DACARBAZINE-VINDESINE VERSUS DACARBAZINE-VINDESINE-CISPLATIN IN DISSEMINATED MALIGNANT-MELANOMA - A RANDOMIZED PHASE-III TRIAL, European journal of cancer, 34(9), 1998, pp. 1368-1374
CENTRAL-NERVOUS-SYSTEM METASTASES OF CUTANEOUS MALIGNANT-MELANOMA - APOPULATION-BASED STUDY
Authors: COHNCEDERMARK G MANSSONBRAHME E RUTQVIST LE LARSSON O JOHANSSON H RINGBORG U
Citation: G. Cohncedermark et al., CENTRAL-NERVOUS-SYSTEM METASTASES OF CUTANEOUS MALIGNANT-MELANOMA - APOPULATION-BASED STUDY, Acta oncologica (Stockholm), 37(5), 1998, pp. 463-470
ALCOHOL AND RISK OF CANCER
Authors: RINGBORG U
Citation: U. Ringborg, ALCOHOL AND RISK OF CANCER, Alcoholism, clinical and experimental research, 22(7), 1998, pp. 323-328
N-RAS MUTATIONS ARE COMMON IN MELANOMAS FROM SUN-EXPOSED SKIN OF HUMANS BUT RARE IN MUCOSAL MEMBRANE OR UNEXPOSED SKIN
Authors: JIVESKOG S RAGNARSSONOLDING B PLATZ A RINGBORG U
Citation: S. Jiveskog et al., N-RAS MUTATIONS ARE COMMON IN MELANOMAS FROM SUN-EXPOSED SKIN OF HUMANS BUT RARE IN MUCOSAL MEMBRANE OR UNEXPOSED SKIN, Journal of investigative dermatology, 111(5), 1998, pp. 757-761
SCREENING OF GERMLINE MUTATIONS IN THE CDK4, CDKN2C AND TP53 GENES INFAMILIAL MELANOMA - A CLINIC-BASED POPULATION STUDY
Authors: PLATZ A HANSSON J RINGBORG U
Citation: A. Platz et al., SCREENING OF GERMLINE MUTATIONS IN THE CDK4, CDKN2C AND TP53 GENES INFAMILIAL MELANOMA - A CLINIC-BASED POPULATION STUDY, International journal of cancer, 78(1), 1998, pp. 13-15
SCREENING OF GERMLINE MUTATIONS IN THE CDKN2A AND CDKN2B GENES IN SWEDISH FAMILIES WITH HEREDITARY CUTANEOUS MELANOMA
Authors: PLATZ A HANSSON J MANSSONBRAHME E LAGERLOF B LINDER S LUNDQVIST E SEVIGNY P INGANAS M RINGBORG U
Citation: A. Platz et al., SCREENING OF GERMLINE MUTATIONS IN THE CDKN2A AND CDKN2B GENES IN SWEDISH FAMILIES WITH HEREDITARY CUTANEOUS MELANOMA, Journal of the National Cancer Institute, 89(10), 1997, pp. 697-702
ON THE MOLECULAR-GENETICS OF MALIGNANT-MELANOMA
Authors: RINGBORG U PLATZ A HANSSON J
Citation: U. Ringborg et al., ON THE MOLECULAR-GENETICS OF MALIGNANT-MELANOMA, European journal of cancer, 33, 1997, pp. 1314-1314
ROLE OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE, GLUTATHIONE TRANSFERASE M3-3 AND GLUTATHIONE IN RESISTANCE TO CARMUSTINE IN A HUMAN NONSMALL CELL LUNG-CANCER CELL-LINE
Authors: EGYHAZI S EDGREN MR HANSSON J KROCKEL D MANNERVIK B RINGBORG U
Citation: S. Egyhazi et al., ROLE OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE, GLUTATHIONE TRANSFERASE M3-3 AND GLUTATHIONE IN RESISTANCE TO CARMUSTINE IN A HUMAN NONSMALL CELL LUNG-CANCER CELL-LINE, European journal of cancer, 33(3), 1997, pp. 447-452
IMMUNOHISTOCHEMICAL EXAMINATION OF THE EXPRESSION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN-MELANOMA METASTASES
Authors: EGYHAZI S MARGISON GP HANSSON J RINGBORG U
Citation: S. Egyhazi et al., IMMUNOHISTOCHEMICAL EXAMINATION OF THE EXPRESSION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN-MELANOMA METASTASES, European journal of cancer, 33(1), 1997, pp. 129-134
PROGNOSTIC VALUE OF SERUM ANALYSES OF S-100 PROTEIN-BETA IN MALIGNANT-MELANOMA
Authors: HANSSON LO VONSCHOULTZ E DJUREEN E HANSSON J NILSSON B RINGBORG U
Citation: Lo. Hansson et al., PROGNOSTIC VALUE OF SERUM ANALYSES OF S-100 PROTEIN-BETA IN MALIGNANT-MELANOMA, Anticancer research, 17(4B), 1997, pp. 3071-3073
NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A RANDOMIZED PHASE-III STUDY
Authors: LEWIN F DAMBER L JONSSON H ANDERSSON T BERTHELSEN A BIORKLUND A BLOMQVIST E EVENSEN JF HANSEN HS HANSEN O JETLUND O MERCKE C MODIG H OVERGAARD M ROSENGREN B TAUSJO J RINGBORG U
Citation: F. Lewin et al., NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A RANDOMIZED PHASE-III STUDY, Radiotherapy and oncology, 43(1), 1997, pp. 23-28
OUTCOMES OF PATIENTS WITH LOCAL RECURRENCE OF CUTANEOUS MALIGNANT-MELANOMA - A POPULATION-BASED STUDY
Authors: COHNCEDERMARK G MANSSONBRAHME E RUTQVIST LE LARSSON O SINGNOMKLAO T RINGBORG U
Citation: G. Cohncedermark et al., OUTCOMES OF PATIENTS WITH LOCAL RECURRENCE OF CUTANEOUS MALIGNANT-MELANOMA - A POPULATION-BASED STUDY, Cancer, 80(8), 1997, pp. 1418-1425
COMPARISON OF INDUCTION CHEMOTHERAPY BEFORE RADIOTHERAPY WITH RADIOTHERAPY ONLY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE LUNG
Authors: BRODIN O NOU E MERCKE C LINDEN CJ LUNDSTROM R ARWIDI A BRINK J RINGBORG U
Citation: O. Brodin et al., COMPARISON OF INDUCTION CHEMOTHERAPY BEFORE RADIOTHERAPY WITH RADIOTHERAPY ONLY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE LUNG, European journal of cancer, 32A(11), 1996, pp. 1893-1900
INHIBITION OF TUMOR-CELL GROWTH BY MONOTERPENES IN-VITRO - EVIDENCE OF A RAS-INDEPENDENT MECHANISM OF ACTION
Authors: KARLSON J BORGKARLSON AK UNELIUS R SHOSHAN MC WILKING N RINGBORG U LINDER S
Citation: J. Karlson et al., INHIBITION OF TUMOR-CELL GROWTH BY MONOTERPENES IN-VITRO - EVIDENCE OF A RAS-INDEPENDENT MECHANISM OF ACTION, Anti-cancer drugs, 7(4), 1996, pp. 422-429
INCREASED CISPLATIN SENSITIVITY OF HUMAN FIBROBLASTS FROM A SUBJECT WITH INHERENT GLUTATHIONE DEFICIENCY
Authors: HANSSON J EDGREN MR EGYHAZI S HAO XY MANNERVIK B RINGBORG U
Citation: J. Hansson et al., INCREASED CISPLATIN SENSITIVITY OF HUMAN FIBROBLASTS FROM A SUBJECT WITH INHERENT GLUTATHIONE DEFICIENCY, Acta oncologica, 35(6), 1996, pp. 683-690
CHEMOTHERAPY RESISTANCE MECHANISMS
Authors: RINGBORG U PLATZ A
Citation: U. Ringborg et A. Platz, CHEMOTHERAPY RESISTANCE MECHANISMS, Acta oncologica, 35(5), 1996, pp. 76-80
PERCEIVED SUSCEPTIBILITY TO AND KNOWLEDGE OF MALIGNANT-MELANOMA - SCREENING PARTICIPANTS VS THE GENERAL-POPULATION
Authors: BRANDBERG Y BOLUND C MICHELSON H MANSSONBRAHME E RINGBORG U SJODEN PO
Citation: Y. Brandberg et al., PERCEIVED SUSCEPTIBILITY TO AND KNOWLEDGE OF MALIGNANT-MELANOMA - SCREENING PARTICIPANTS VS THE GENERAL-POPULATION, Preventive medicine, 25(2), 1996, pp. 170-177
MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE
Authors: MARGISON GP RAFFERTY JA ELDER RH KELLY J WATSON AJ WILLINGTON MA LEE SM HICKSON I FAIRBAIRN LJ DEXTER TM JELINEK J STOCKING C BAUM C OSTERTAG W EGHYAZI S HANSSON J RINGBORG U DONNELLY D MCMURRY TBH MCCORMICK J MCELHINNEY RS
Citation: Gp. Margison et al., MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE, Medicamentos de actualidad, 32, 1996, pp. 51-59
PREDICTORS OF LATE MORTALITY IN CUTANEOUS MALIGNANT-MELANOMA - A POPULATION-BASED STUDY IN SWEDEN
Authors: THORN M BERGSTROM R HEDBLAD M LAGERLOF B RINGBORG U ADAMI HO
Citation: M. Thorn et al., PREDICTORS OF LATE MORTALITY IN CUTANEOUS MALIGNANT-MELANOMA - A POPULATION-BASED STUDY IN SWEDEN, International journal of cancer, 67(1), 1996, pp. 38-44
RESECTION MARGINS OF 2 VERSUS 5 CM FOR CUTANEOUS MALIGNANT-MELANOMA WITH A TUMOR THICKNESS OF 0.8 TO 2.0 MM - A RANDOMIZED STUDY BY THE SWEDISH MELANOMA STUDY-GROUP
Authors: RINGBORG U ANDERSSON R ELDH J GLAUMANN B HAFSTROM L JACOBSSON S JONSSON PE JOHANSSON H KRYSANDER L LAGERLOF B CHRISTER L BJORN N CARLMAGNUS R ERIK RL GUNNAR W ATHLIN L BERGMAN O CARLSSON L COSMO P DANIELSSON H ERIKSSON M GRENABO J GUSTAVSSON L HAGHJOO A HOLMNER S HOGMAN L INGVAR C JANSSON K JASKA F LINDMARK L MOELL PO MOSSBERG I OHLSSON E PERSSON NA SEGERSTROM A SELLSTROM H THOLIN B WIDMAN BG WIREN M OHRN PG
Citation: U. Ringborg et al., RESECTION MARGINS OF 2 VERSUS 5 CM FOR CUTANEOUS MALIGNANT-MELANOMA WITH A TUMOR THICKNESS OF 0.8 TO 2.0 MM - A RANDOMIZED STUDY BY THE SWEDISH MELANOMA STUDY-GROUP, Cancer, 77(9), 1996, pp. 1809-1814
GENES INVOLVED IN CELL-CYCLE G(1) CHECKPOINT CONTROL ARE FREQUENTLY MUTATED IN HUMAN-MELANOMA METASTASES
Authors: PLATZ A SEVIGNY P NORBERG T RING P LAGERLOF B RINGBORG U
Citation: A. Platz et al., GENES INVOLVED IN CELL-CYCLE G(1) CHECKPOINT CONTROL ARE FREQUENTLY MUTATED IN HUMAN-MELANOMA METASTASES, British Journal of Cancer, 74(6), 1996, pp. 936-941
MUTATIONAL ANALYSIS OF THE CDKN2 GENE IN METASTASES FROM PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA
Authors: PLATZ A RINGBORG U LAGERLOF B LUNDQVIST E SEVIGNY P INGANAS M
Citation: A. Platz et al., MUTATIONAL ANALYSIS OF THE CDKN2 GENE IN METASTASES FROM PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA, British Journal of Cancer, 73(3), 1996, pp. 344-348
2ND PRIMARY CANCERS IN PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA - APOPULATION-BASED STUDY IN SWEDEN
Authors: WASSBERG C THORN M YUEN J RINGBORG U HAKULINEN T
Citation: C. Wassberg et al., 2ND PRIMARY CANCERS IN PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA - APOPULATION-BASED STUDY IN SWEDEN, British Journal of Cancer, 73(2), 1996, pp. 255-259
CUTANEOUS MALIGNANT-MELANOMA
Authors: RINGBORG U
Citation: U. Ringborg, CUTANEOUS MALIGNANT-MELANOMA, Acta oto-laryngologica, 116(5), 1996, pp. 641-646
Risultati: 1-25 | 26-44